SCHEMBL23947709

SCHEMBL23947709

c1ccc(-c2nc(-c3ccccc3)nc(-c3cncc4oc5ccc(-c6ccc7ccccc7c6)cc5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 3/20 0.40
CYP1A2 P05177 2/20 0.40
TP53 P04637 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP11B1 P15538 4/20 0.40
CYP11B2 P19099 4/20 0.40
CYP17A1 P05093 1/20 0.40
CYP19A1 P11511 1/20 0.40
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22698273 0.93 PLA2G2A (0.38) ALDH1A1SMN1; SMN2MEN1KMT2APIK3CD
SCHEMBL23944537 0.92 KDM4E (0.39) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL24762187 0.92 KDM4E (0.41) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL24762323 0.91 KDM4E (0.39) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL25508741 0.91 KDM4E (0.40) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL25508744 0.91 KDM4E (0.40) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL25508409 0.91 KDM4E (0.40) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL23944559 0.91 KDM4E (0.40) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL23944820 0.91 CYP11B1 (0.38) KDM4EALDH1A1HSD17B10CYP1A2TP53
SCHEMBL25508981 0.91 CYP11B1 (0.40) KDM4EALDH1A1HSD17B10CYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-06-08 US disclosed
WO-2021210911-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174544-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY2, CYBA, AHR KDM4E 2876/4885ALDH1A1 484/4885HSD17B10 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.